Guardant Health Inc Total Liabilities
Guardant Health Inc total liabilities. Based on the latest financial reports, Guardant Health Inc (GH) has total liabilities worth $2.10 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Guardant Health Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guardant Health Inc (2016–2025)
Total liabilities of Guardant Health Inc from 2016 to 2025. This chart illustrates how Guardant Health Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Guardant Health Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Guardant Health Inc Competitors by Total Liabilities
The table below lists competitors of Guardant Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yunnan Aluminium Co Ltd
SHE:000807
|
China | CN¥11.08 Billion |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
USA | $3.72 Billion |
|
GRAB HOLDINGS LTD CL.A
F:A6I
|
Germany | €5.23 Billion |
|
Taiwan Mobile Co Ltd
TW:3045
|
Taiwan | NT$145.33 Billion |
|
Wolters Kluwer N.V.
AS:WKL
|
Netherlands | €8.79 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥19.76 Billion |
|
LATAM Airlines Group S.A.
NYSE:LTM
|
USA | $16.78 Billion |
|
SEI Investments Company
NASDAQ:SEIC
|
USA | $788.47 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Guardant Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Guardant Health Inc assets under control.
Liquidity & Leverage Metrics
Guardant Health Inc Total Liabilities Ratios Explained
Guardant Health Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -11.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guardant Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guardant Health Inc (2016–2025)
The table below shows the annual total liabilities of Guardant Health Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $2.11 Billion | +30.01% |
| 2024-12-31 | $1.63 Billion | -0.15% |
| 2023-12-31 | $1.63 Billion | +5.03% |
| 2022-12-31 | $1.55 Billion | -0.62% |
| 2021-12-31 | $1.56 Billion | +70.22% |
| 2020-12-31 | $916.19 Million | +699.87% |
| 2019-12-31 | $114.54 Million | +83.41% |
| 2018-12-31 | $62.45 Million | +81.90% |
| 2017-12-31 | $34.33 Million | -6.88% |
| 2016-12-31 | $36.87 Million | -- |
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tu… Read more